nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico
|
Garnica-Cuellar, Juan Carlos |
|
|
|
5 |
p. 841-849 |
artikel |
2 |
Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland
|
Brock, Elisabeth |
|
|
|
5 |
p. 735-743 |
artikel |
3 |
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn’s Disease and Ulcerative Colitis
|
Loftus, Edward V. |
|
|
|
5 |
p. 823-840 |
artikel |
4 |
Correction: Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England
|
Bromilow, Tom |
|
|
|
5 |
p. 861 |
artikel |
5 |
Cost-Effectiveness Analysis of a Medial Meniscus Replacement Prosthesis for the Treatment of Patients with Medial Compartment Pain in the United Kingdom
|
Javanbakht, Mehdi |
|
|
|
5 |
p. 681-696 |
artikel |
6 |
Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England
|
Bromilow, Tom |
|
|
|
5 |
p. 739-750 |
artikel |
7 |
Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease
|
Shupo, Francis |
|
|
|
5 |
p. 777-792 |
artikel |
8 |
Cost Effectiveness of Different Platelet Preparation, Storage, Selection and Dosing Methods in Platelet Transfusion: A Systematic Review
|
Laermans, Jorien |
|
|
|
5 |
p. 679-708 |
artikel |
9 |
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
|
Westerink, Lotte |
|
|
|
5 |
p. 647-656 |
artikel |
10 |
Cost of Surgical Care at Public Sector District Hospitals in India: Implications for Universal Health Coverage and Publicly Financed Health Insurance Schemes
|
Singh, Maninder Pal |
|
|
|
5 |
p. 745-756 |
artikel |
11 |
Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX)
|
Hunter, Rachael |
|
|
|
5 |
p. 723-733 |
artikel |
12 |
Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina
|
Garay, Osvaldo Ulises |
|
|
|
5 |
p. 657-668 |
artikel |
13 |
Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067
|
Baker, Timothy |
|
|
|
5 |
p. 697-710 |
artikel |
14 |
Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases
|
Karki, Chitra |
|
|
|
5 |
p. 811-822 |
artikel |
15 |
Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in Denmark
|
Vestergaard, Anne Høy Seemann |
|
|
|
5 |
p. 751-764 |
artikel |
16 |
Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review
|
Jovanoski, Nick |
|
|
|
5 |
p. 723-738 |
artikel |
17 |
Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
|
Khair, Andrew |
|
|
|
5 |
p. 851-860 |
artikel |
18 |
How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments
|
Gomez Montero, Melissa |
|
|
|
5 |
p. 637-646 |
artikel |
19 |
Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis
|
Jhaveri, Kenar D. |
|
|
|
5 |
p. 709-722 |
artikel |
20 |
Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data
|
Philipson, Anna |
|
|
|
5 |
p. 765-776 |
artikel |
21 |
Perceptions and Attitudes Regarding Medical Device Development in Canada Among Canadian Innovators: A Qualitative Study
|
Browne, Ikennah L. |
|
|
|
5 |
p. 793-809 |
artikel |
22 |
Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment
|
Darrudi, Alireza |
|
|
|
5 |
p. 669-679 |
artikel |
23 |
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland
|
Ward, Thomas |
|
|
|
5 |
p. 757-771 |
artikel |
24 |
The Physician and Administrator-Reported Cost of Drug Utilization Management to Physician Practices: A Cross-Sectional Survey
|
Edwards, Marie Louise |
|
|
|
5 |
p. 711-721 |
artikel |
25 |
Using Health Economics to Inform Immunization Policy Across All Levels of Government
|
Rafferty, Ellen |
|
|
|
5 |
p. 631-635 |
artikel |